Therapeutics: Glycogen dependent kinase 3 (GSK3); dyskerin pseudouridine synthase 1 (DKC1)

Other

INDICATION: Dyskeratosis congenita

Patient sample and cell culture studies suggest GSK3 inhibitors could help treat dyskeratosis congenita, which is caused

Read the full 193 word article

How to gain access

Continue reading with a
two-week free trial.